Q1 2016
Released May 9, 2016, after the close
10-Q filed May 9, 2016, 39 days after period end · 0001144204-16-099991
Q1 2016 · 10-Q
Revenue—
Net Income-$7.01M-$7.01M N/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$0.38-$0.38 N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$7,070,404N/M
Operating Cash Flow-$6,509,120N/M
Free Cash Flowderived-$6,548,322N/M
What the release said
The release
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$7.01M | -$2.96M | -$5.27M | -$1.35M |
| EPS Diluted | -$0.38 | -$0.23 | -$0.41 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR